Evidence mapPaperPMID 39334769Full record

ArticleAntioxidants (Basel, Switzerland)2024

Senescence Rejuvenation through Reduction in Mitochondrial Reactive Oxygen Species Generation by

Jee Hee Yoon, Ye Hyang Kim, Eun Young Jeong, Yun Haeng Lee, Youngjoo Byun, Song Seok Shin, Joon Tae Park

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. 2-Methoxystypandrone fromAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Leveraging mitochondrial stress to improve healthy aging.Sports medicine and health science · 2026
    Review
  3. ε-Viniferin Rejuvenates Senescence viaPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Epigallocatechin Gallate inPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jee Hee YoonDivision of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
Ye Hyang KimHyundai Bioland Co., Ltd., 22, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28162, Republic of Korea.
Eun Young JeongHyundai Bioland Co., Ltd., 22, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28162, Republic of Korea.
Yun Haeng LeeDivision of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
Youngjoo ByunCollege of Pharmacy, Korea University, Sejong 30019, Republic of Korea.ORCID 0000-0002-0297-7734
Song Seok ShinHyundai Bioland Co., Ltd., 22, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28162, Republic of Korea.
Joon Tae ParkDivision of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.ORCID 0000-0003-2396-9108

Funding

Korea Health Industry Development Institute HP23C0024
6 · The paper itself

Abstract

Oxidative stress caused by reactive oxygen species (ROS) is one of the major causes of senescence. Strategies to reduce ROS are known to be important factors in reversing senescence, but effective strategies have not been found. In this study, we screened substances commonly used as cosmetic additives to find substances with antioxidant effects.

Indexed as

oxidative stressPolygonum cuspidatumreactive oxygen species (ROS)senescence rejuvenationskin aging

Identifiers

PMID39334769
PMCPMC11429016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.